TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive NCI Advisors Approve Recompetition Of $132 Million Proteomic Technologies Network March 12, 2010
TCL Archive Group Chairs: Research In “Crisis” ASCO Says NCTN Budgets Cut By 40 Percent, Warns of “Dangerous Disruption of Cancer Care” April 4, 2014